Re: Cost-efficiency analyses for the US of biosimilar...

  • Main
  • 2018 / 03
  • Re: Cost-efficiency analyses for the US of biosimilar...

Re: Cost-efficiency analyses for the US of biosimilar filgrastim-sndz, reference filgrastim, pegfilgrastim, and pegfilgrastim with on-body injector in the prophylaxis of chemotherapy-induced (febrile) neutropenia

Bensink, Mark, Edwards, Christine, Bowers, Charles, Campbell, Jon
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Journal of Medical Economics
DOI:
10.1080/13696998.2018.1452747
Date:
March, 2018
File:
PDF, 582 KB
english, 2018
Conversion to is in progress
Conversion to is failed